TDO2 and renal cell carcinoma: In combination with clinicopathologic features, TDO2 expression was associated with advanced T grade (p = 0.0002), M grade (p = 0.0199), advanced stage (p = 0.0023), and poor survival in TCGA RCC data (Fig. 1b).